Facebook
Twitter
LinkedIn
ForwardMayo Clinic Cardio-Oncology Update 2021 - General Session - LIVESTREAM
This is the LIVESTREAM attendance option for the General Session
Course Directors: Reza Arsanjani, M.D., Brian W. Hardaway, M.D., Joerg Herrmann, M.D., Thai H. Ho, M.D., Ph.D., Carolyn M. Larsen, M.D., and Donald W. Northfelt, M.D.
November 4 - 6, 2021 - Fairmont Scottsdale Princess - Scottsdale, Arizona
This course will cover key updates in cardio-oncology clinical practice and research over the last year, and also review key fundamental topics regarding the management of cardiac and vascular diseases affecting patients with cancer and cancer survivors. Fundamental topics will include heart failure, myocarditis, vascular disease, and arrhythmias associated with cancer therapies, as well as the cardiac effects of radiation therapy.
The interactive format will include case presentations, state-of-the-art lectures, and the opportunity for attendees to submit challenging cases for group discussion. The goals of the course are to improve quality, safety and outcomes for cancer patients with cardiac disease and to bring together members of the cardio-oncology community to learn from each other's experiences.
| Registration Fee ( Livestream) | |
|---|---|
| General Session | |
| M.D., D.O., Ph.D. | $899 |
| Allied Health, NP, PA, Retirees | $799 |
Target Audience
This course is designed for general cardiologists, heart failure specialists, and advanced practice providers working in cardiology who either currently practice cardio-oncology or aim to expand their practice into the field to optimize the care of this patient population. The course is also designed for providers in hematology, oncology, and internal medicine as they are often the first to encounter and diagnose patients with cardiotoxicity related to cancer therapies.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify classes of chemotherapeutic agents commonly associated with cardiovascular risk
- Outline appropriate cardiac surveillance plans for patients receiving cancer therapies with potential cardiac toxicities
- Describe treatment and manage myocarditis secondary to checkpoint inhibitor therapy
- Describe treatment and manage hypertension secondary to tyrosine kinase inhibitor therapy
- Describe treatment and manage heart failure secondary to cancer therapy
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Click here to view Program Schedule on mobile
Course Directors:
Reza Arsanjani, M.D.
Brian W. Hardaway, M.D.
Joerg Herrmann, M.D.
Thai H. Ho, M.D., Ph.D.
Carolyn M. Larsen, M.D.
Donald W. Northfelt, M.D.
Guest Faculty:
Daniel J. Lenihan, M.D., FAACC, FESC
Washington University in St. Louis
St. Louis, Missouri
Tomas G. Neilan, M.D.
Harvard University
Cambridge, Massachusetts
Mayo Clinic Faculty:
Januario E. Castro, M.D.
Hicham Z. El Masry, M.D.
Regis I. Fernandes, M.D.
William K. Freeman, M.D.
Kevin L. Greason, M.D.
Martha Grogan, M.D.
Sameer R. Keole, M.D.
Kyle W. Klarich, M.D.
Carolyn Landolfo, M.D.
Jeremy T. Larsen, M.D.
S. Allen Luis, M.B.B.S.
Joseph J. Maleszewski, M.D.
Sunil V. Mankad, M.D.
Hemalatha (Hema) Narayanasamy, M.B.B.S.
Jeanne M. Palmer, M.D.
Naveen L. Pereira, M.D.
Samine Ravanbakhsh, M.D.
Jordan (Chris) C. Ray, M.D.
Martin G. Rodriguez-Porcel, M.D..
Kathryn J. Ruddy, M.D.
Shimoli V. Shah, M.D.
Fadi E. Shamoun, M.D., Ph.D.
Mohamad (Bassam) B. Sonbol, M.D.
D. Eric Steidley, M.D.
Hector R. Villarraga, M.D.
Susan Wilansky, M.D.
Waldemar E. Wysokinski, M.D., Ph.D.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this other activity (live and livestream) for a maximum of 16.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 16.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AOA
The American Osteopathic Association designates this program for a maximum of 16.50 AOA Category 2-A credits.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Credit Breakdown | General Session |
| Thursday | 6.25 |
| Friday | 6.25 |
| Saturday | 4.00 |
| TOTAL | 16.50 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 16.50 ABIM
- 16.50 AMA PRA Category 1 Credit™
- 16.50 ANCC
- 16.50 AOA Category 2-A
- 16.50 Attendance
For information regarding exhibit opportunities, please reach out to Kristy Badder.
Price
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.